<?xml version="1.0" encoding="UTF-8"?>
<p>Physicians should be aware of the adverse effects, typical of each treatment class prescribed at this stage of treatment and the need for specific clinical and laboratory monitoring before and during use. For immunosuppressive drugs, specific tests are required, such as screening for hepatitis B (hepatitis B surface antigen, antibodies to hepatitis B surface antigen, antibodies to hepatitis B core antigen), hepatitis C (antibody to hepatitis C virus) and human immunodeficiency virus, the Mantoux test, and chest x-ray. </p>
